- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹43 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 4 Jun 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,530
Prism Medico and Pharmacy routine notices
105 filed, newest first. Page 3 of 3.
Aug 2015
8 Aug · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on August 14, 2015, inter alia, to consider and approve the ....
May 2015
19 May · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2015, inter alia, to consider and approve Audited ....
Nov 2014
13 Nov · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on November 14, 2014, inter alia, to consider and approve ....
Aug 2014
4 Aug · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2014, inter alia, to consider and approve Unaudited ....
May 2014
21 May · Routine
Meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2014, inter alia, to consider and approve Audited ....